Study Progress in Combined Application of Chinese Medicines and 5-Hydroxytryptamine Reuptake Inhibi-tors
10.3969/j.issn.1008-049X.2017.09.014
- VernacularTitle:中药与5-羟色胺再摄取抑制类抗抑郁药联合应用的研究进展
- Author:
Meng QIAN
;
Ming XIE
- Keywords:
Antidepressants;
Chinese medicines;
Selective 5-hydroxytryptamine reuptake inhibitors;
Combined drug use
- From:
China Pharmacist
2017;20(9):1573-1578
- CountryChina
- Language:Chinese
-
Abstract:
At present, selective 5-hydroxytryptamine (5-HT) reuptake inhibitors (SSRIs) and 5-HT and noradrenaline (NA) re-uptake inhibitors ( SNaRI) are the first choice for the clinical treatment of depression, however, the clinical adverse effects of the drugs have become a prominent problem affecting the clinical efficacy. Chinese medicines have some experience in the treatment of depres-sion, and the combined use with the above antidepressants can enhance the efficacy and / or reduce the adverse effects. The article re-viewed the status of the combination of SSRIs and Chinese medicines in order to provide reference for the clinical treatment of depres-sion.
